Assessing the safety of COVID-19 vaccines using advanced statistical methods
A risk-varying and perturbed self-controlled case series design for assessing the safety of COVID-19 vaccines in a large health care system
This study is looking into how safe COVID-19 vaccines are, especially focusing on concerns about serious side effects like blood clots, to help people make better choices about getting vaccinated.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11076736 on NIH RePORTER |
What this research studies
This research investigates the safety of COVID-19 vaccines by developing new statistical models that can accurately assess the risk of severe adverse events (SAEs) associated with these vaccines. It aims to address concerns about vaccine safety, particularly regarding blood clots linked to the Janssen vaccine and the two-dose mRNA vaccines. By analyzing existing healthcare data and improving methodologies for evaluating vaccine safety, the research seeks to provide clearer insights into the risks involved in vaccination. Patients may benefit from enhanced safety monitoring and more informed decisions regarding COVID-19 vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have received or are considering receiving COVID-19 vaccines and have concerns about potential adverse effects.
Not a fit: Patients who have not received any COVID-19 vaccines or those who are not considering vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved safety assessments of COVID-19 vaccines, helping to alleviate vaccine hesitancy and promote public health.
How similar studies have performed: Other research has successfully utilized advanced statistical methodologies to assess vaccine safety, indicating that this approach has potential for meaningful insights.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Xu, Stanley — Kaiser Foundation Research Institute
- Study coordinator: Xu, Stanley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.